TrademarkOpen
Search / United States / 97604872

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark

OCULO

Allowed — statement of use stage
Fifth Extension - Granted
Used for: Pharmaceutical preparations for the treatment of ophthalmic diseases or conditions, namely, glaucoma

Class 5 – Pharmaceuticals & supplements

Status timeline

  1. 27 Sep 2022
    Application filed
    New Application Entered
  2. 6 Jul 2023
    Assigned to an examining attorney
    Assigned To Examiner
  3. 18 Sep 2023
    Assigned to an examining attorney
    Assigned To Examiner
  4. 26 Sep 2023
    Approved for publication
    Approved For Pub - Principal Register
  5. 31 Oct 2023
    Published for opposition
    Published For Opposition
  6. 26 Dec 2023
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  7. 24 Jun 2024
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  8. 1 Nov 2024
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
  9. 29 Mar 2025
    Statement-of-use extension 3 granted
    Sou Extension 3 Granted
All 35 events
2026-08-15Notice Of Approval Of Extension Request E-Mailed
2026-08-14Case Assigned To Intent To Use Paralegal
2026-08-14Sou Extension 5 Granted
2026-05-29Sou Teas Extension Received
2026-05-29Sou Extension 5 Filed
2026-05-01Teas Change Of Owner Address Received
2026-05-01Applicant/Correspondence Changes (Non-Responsive) Entered
2026-05-01Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
2026-05-01Attorney/Dom.rep.revoked And/Or Appointed
2026-05-01Teas Change Of Correspondence Received
2025-12-02Notice Of Approval Of Extension Request E-Mailed
2025-12-01Sou Teas Extension Received
2025-12-01Sou Extension 4 Filed
2025-12-01Sou Extension 4 Granted
2025-03-29Sou Extension 3 Granted
2025-03-29Notice Of Approval Of Extension Request E-Mailed
2025-03-28Sou Teas Extension Received
2025-03-28Sou Extension 3 Filed
2024-11-01Sou Teas Extension Received
2024-11-01Sou Extension 2 Filed
2024-11-01Sou Extension 2 Granted
2024-11-01Notice Of Approval Of Extension Request E-Mailed
2024-06-24Sou Teas Extension Received
2024-06-24Sou Extension 1 Filed
2024-06-24Sou Extension 1 Granted
2024-06-24Notice Of Approval Of Extension Request E-Mailed
2023-12-26Noa Mailed - Sou Required From Applicant
2023-10-31Published For Opposition
2023-10-31Official Gazette Publication Confirmation E-Mailed
2023-10-11Notification Of Notice Of Publication E-Mailed
2023-09-26Approved For Pub - Principal Register
2023-09-18Assigned To Examiner
2023-07-06Assigned To Examiner
2022-10-11New Application Office Supplied Data Entered
2022-09-27New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Pharmaceutical preparations for the treatment of ophthalmic diseases or conditions, namely, glaucoma

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 15 Aug 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.